Aprogen Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Aprogen Pharmaceuticals Inc cash flow-to-debt ratio. Aprogen Pharmaceuticals Inc (003060) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of ₩-7.66 Billion could theoretically repay 0% of its total liabilities (₩288.27 Billion) in one year. Check Aprogen Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Aprogen Pharmaceuticals Inc (2010–2024)
Cash flow-to-debt ratio of Aprogen Pharmaceuticals Inc from 2010 to 2024. Historical debt coverage capacity for Aprogen Pharmaceuticals Inc across 13 annual periods. Check Aprogen Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Aprogen Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2010–2024)
Aprogen Pharmaceuticals Inc cash flow-to-debt ratio by year from 2010 to 2024. Year-by-year debt coverage analysis for Aprogen Pharmaceuticals Inc. For the full cash flow conversion analysis, see 003060 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.15x | ₩-31.00 Billion | ₩212.29 Billion | ▲ +4.2% |
| 2023 | -0.15x | ₩-33.65 Billion | ₩220.71 Billion | ▼ -203.0% |
| 2022 | 0.15x | ₩25.73 Billion | ₩173.73 Billion | ▲ +141.5% |
| 2021 | -0.36x | ₩-6.23 Billion | ₩17.44 Billion | ▼ -174.8% |
| 2020 | 0.48x | ₩8.09 Billion | ₩16.95 Billion | ▲ +1079.5% |
| 2019 | 0.04x | ₩713.73 Million | ₩17.65 Billion | ▲ +102.2% |
| 2018 | 0.02x | ₩1.33 Billion | ₩66.55 Billion | ▲ +118.0% |
| 2017 | -0.11x | ₩-8.93 Billion | ₩80.41 Billion | ▼ -1347.7% |
| 2016 | 0.01x | ₩449.98 Million | ₩50.57 Billion | ▼ -91.6% |
| 2015 | 0.11x | ₩1.85 Billion | ₩17.48 Billion | ▲ +134.7% |
| 2014 | -0.30x | ₩-6.92 Billion | ₩22.71 Billion | ▼ -288.5% |
| 2013 | -0.08x | ₩-1.70 Billion | ₩21.71 Billion | ▼ -1234.7% |
| 2010 | 0.01x | ₩247.92 Million | ₩35.89 Billion | — |